<DOC>
	<DOCNO>NCT00001656</DOCNO>
	<brief_summary>The purpose study compare effectiveness side effect drug clozapine olanzapine child adolescent schizophrenia psychosis . Childhood psychosis serious disorder may devastate consequence . Effective treatment condition continual investigation . This study examine cause offer treatment childhood psychosis . Participants study undergo psychological test , blood urine test , electroencephalogram ( EEG ) , electrocardiogram ( EKG ) , magnetic resonance imaging ( MRI ) scan brain first 1 2 week study take regular medication . Participants taper medication 1 3 week continue stay medication additional 2 day 3 week . During time , participant undergo psychiatric , neurological , cardiac examination well blood test . After period without medication , participant randomly assign receive either clozapine olanzapine 8 week . An EEG perform prior treatment 6 week study medication . Participants respond well study drug may continue receive physician . Participants respond either clozapine olanzapine tolerate side effect treat individually drug optimum treatment identify . Regular telephone update person visit NIH repeat test MRIs conduct .</brief_summary>
	<brief_title>Comparison Clozapine v Olanzapine Childhood-Onset Psychotic Disorders</brief_title>
	<detailed_description>The purpose protocol compare efficacy clozapine olanzapine child adolescent schizophrenia psychosis , well learn side effect medication pediatric population . The underlying hypothesis clozapine superior efficacy olanzapine . Children adolescent , age 7 18 year , meet DSM-IV criterion schizophrenia , schizoaffective disorder psychotic disorder otherwise specify , onset psychosis 13th birthday , respond least two prior trial typical typical neuroleptic , eligible participate double-blind , parallel group , trial olanzapine-clozapine . This study do conjunction Screening protocol , include characterization clinical phenomenology , eye tracking , MRI brain imaging , plasma biochemistry , chromosomal analysis . This study consist follow phase 1 ) Tapering psychotropic medication ( 1-4 week , depend upon type dosage ) . 2 ) Observation 2 week drug free , order establish baseline prior start medication trial . 3 ) An 8 week double-blind trial either clozapine olanzapine . Efficacy tolerability clozapine olanzapine compare use specify criterion . 4 ) If desire improvement achieve trial interrupt , 8 week open trial second medication 5 ) Discharge follow medication optimization 4 week , clinically appropriate . This protocol also include follow-up every 2 3 year period 10 year .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Schizophrenia , Childhood</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>INCLUSION CRITERIA : Males female , age 7 18 year Onset psychotic symptom 13th birthday DSMIV diagnosis either schizophrenia , schizoaffective disorder , MDI syndrome , psychosis NOS ( otherwise specify ) . Current significant impairment due illness ( current psychotic symptom , decline function academically socially , significant discomfort due psychotic symptom ) . Failure two prior trial antipsychotic medication ( either typical atypical ) use adequate dos ( great equal 100 mg/day chlorpromazine equivalent ) adequate duration ( least 4 week , unless terminate due intolerable side effect ) . Failure define either insufficient response persistence symptom significantly impair child 's functioning , accord child 's parental report medical school record , intolerable side effect drug clozapine olanzapine . Subjects may include previous trial ( ) olanzapine fail reach dose 20. mg/day duration few four week . Subjects may include previous trial ( ) clozapine fail reach dose 200. mg/day duration few six week . Comorbid psychiatric disorder past 12 month permit long clinically significant . EXCLUSION CRITERIA : Prepsychotic fullscale IQ le 70 . Unstable major neurological medical condition . Current pregnancy plan become pregnant first three month ( duration study ) woman childbearing age ; breastfeed woman infant . DSMIV substance abuse dependence past 6 month . True nonresponders either olanzapine clozapine . True nonresponse define : ) intolerance either medication prevent adequate trial , b ) minimal ( le 20 % ) benefit adequate trial either medication . Adequate trial constitutes least 8 week medication dose 20 mg olanzapine 200 mg clozapine .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Clozapine</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Drug Response</keyword>
	<keyword>Safety</keyword>
	<keyword>Childhood Onset Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Multidimensionally Impaired Syndrome</keyword>
	<keyword>Phenomenology</keyword>
	<keyword>Biochemical Correlates</keyword>
	<keyword>Brain Imaging</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Childhood Schizophrenia</keyword>
	<keyword>Psychosis</keyword>
</DOC>